 |
|
|
|
| Selected Reading |
 Adams MM, Rice AD, Moyer RW. Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox. J Virol 2007 Oct;81(20):11084-95 [Abstract]
Agwunobi JO. Should the US and Russia destroy their stocks of smallpox virus? (head-to-head) BMJ 2007 Apr 14;334(7597):775 [Excerpt]
Aldaz-Carroll L, Xiao Y, Whitbeck JC, et al. Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6. J Virol 2007 Aug;81(15):8131-9 [Abstract]
Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007 Nov 8;3557(19):1903-15 [Abstract]
Amara RR, Nigam P, Sharma S, et al. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol 2004 Apr;78(8):3811-6 [Abstract]
Ambrose CT. Osler and the infected letter. (Historical review) Emerg Infect Dis 2005 May;11(5):689-93 [Full text]
Anis E, Leventhal A, Slater A, et al. Smallpox revaccination of 21000 first responders in Israel: lessons learned. Int J Infect Dis 2009 May;13(3):403-9 [Abstract]
Annas GJ. Bioterrorism, public health, and civil liberties. N Engl J Med 2002;346(17):1337-42 [Full text]
Arita I. Where should we keep smallpox virus? (Letter) Biosecur Bioterror 2011 May 25;9(2):189 [Full text]
Arness MK, Eckart RE, Love SS, et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 2004 Oct 1;160(7):642-1 [Abstract]
Artenstein AW. New generation smallpox vaccines: a review of preclinical and clinical data. Rev Med Virol 2008 Jul-Aug;18(4):217-31 [Abstract]
Baggs J, Chen RT, Damon IK, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis 2005 Apr 15;40(8):1133-40 [Abstract]
Baron S, Pan J, Poast J. Frequency of revaccination against smallpox. (Commentary) Emerg Infect Dis 2003 Nov;9(11):1489-90 [Full text]
Bartlett J, Borio L, Radonovich L, et al. Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 2003 Apr 1;36(7):883-902 [Full text]
Bartlett JG. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. Clin Infect Dis 2003 Feb 15;36(4):468-71 [Abstract]
Bartlett JG. Smallpox vaccination and the patient with HIV/AIDS. Johns Hopkins Center for Biodefense Strategies. Baltimore, Md. 2002 [Full text]
Bass SB, Gordon TF, Ruzek SB, et al. Mapping perceptions related to acceptance of smallpox vaccination by hospital emergency room personnel. Biosecur Bioterror 2008 Jun;6(2):179-90 [Abstract]
Bass SB, Ruzek SB, Gordon TF, et al. Preparedness for a smallpox outbreak: comparing metrics for assessing levels of vaccination among health-care workers by state. Epidemiol Infect 2007 May;135(4):622-33 [Abstract]
Bauch CT, Galvani AP, Earn DJD. Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci 2003 Sep 2;100(18):10564-7 [Abstract]
Baxby D. Smallpox vaccination techniques. 2. Accessories and aftercare. Vaccine 2003 Mar 28;21(13-14):1382-90 [Abstract]
Baxby D. Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine 2002 May 15;20(16):2140-9 [Abstract]
Beachkofsky TM, Carrizales SC, Bidinger JJ, et al. Adverse events following smallpox vaccination with ACAM2000 in a military population. Arch Dermatol 2010 Jun;146(6):656-61 [Abstract]
Belshe RB, Newman FK, Frey SE, et al. Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis 2004 Feb 1;189(3):493-7 [Abstract]
Belyakov IM, Earl P, Dzutsev A, et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci 2003 Aug 5;100(16):9458-63 [Abstract]
Berhanu A, King DS, Mosier S, et al. Impact of ST-246 on ACAM2000 smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice. Vaccine 2010 Dec 16;29(2):289-303 [Abstract]
Berhanu A, Wilson RL, Kirkwood DL, et al. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. J Virol 2008 Apr;82(7):3517-29 [Abstract]
Bessinger GT, Smith SB, Olivere JW, et al. Benign hypersensitivity reactions to smallpox vaccine. Int J Dermatol 2007 May;46(5):460-5 [Abstract]
Bhattacharya S. Reflections on the eradication of smallpox. Lancet Infect Dis 2010 May 8;375(9726):1602-3 [Full text]
Bicknell W, James K. The new cell culture smallpox vaccine should be offered to the general population. Rev Med Virol 2003 Jan-Feb;13(1):5-15 (see also Mortimer 2003 below) [Abstract]
Bicknell WJ, Bloem KD. Smallpox and bioterrorism: why the plan to protect the nation is stalled and what to do. CATO Institute Briefing paper No. 85. Sep 5, 2003 [Full text]
Bicknell WJ. The case for voluntary smallpox vaccination. (Sounding Board) N Engl J Med 2002;346(17):1323-5 [Full text]
Bielinska AU, Chepurnov AA, Landers JJ, et al. A novel, killed-virus nasal vaccinia vaccine. Clin Vaccine Immunol 2008 Feb;15(2):348-58 [Abstract]
Blendon RJ, DesRoches CM, Benson JM, et al. The public and the smallpox threat. N Engl J Med 2003 Jan 30;348(5):426-32 [Full text]
Bossi P, Gay F, Fouzai I, et al. Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers. PLoS ONE 2008 Dec 31;3(12):e4087 [Full text]
Bray M, Buller M. Looking back at smallpox. Clin Infect Dis 2004 Mar 15;38(6):882-9 [Abstract]
Bray M, Wright ME. Progressive vaccinia. Clin Infect Dis 2003 Mar 15;36(6):766-74 [Abstract]
Breman JG, Arita I, Fenner F. Preventing the return of smallpox. N Engl J Med 2003 Jan 30;348(5):463-6 [Full text]
Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346(17):1300-8 [Full text]
Brisson M, Melkonyan G, Drolet M, et al. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010 Apr 26;28(19):3385-97 [Full text]
Brouwers L, Boman M, Camitz M, et al. Micro-simulation of a smallpox outbreak using official register data. Euro Surveill 2010 Sep 2;15(35):pii=19651 [Full text]
Buchman GW, Cohen ME, Xiao Y, et al. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine 2010 Sep 14;28(40):6627-36 [Abstract]
Burke DS, Epstein JM, Cummings DAT, et al. Individual-based computational modeling of smallpox epidemic control strategies. Acad Emerg Med 2006 Nov;13(11):1142-9 [Abstract]
Byrd CM, Bolken TC, Mjalli AM, et al. New class of orthopoxvirus antiviral drugs that block viral maturation. J Virol 2004 Nov;78(22):12147-56 [Abstract]
Byun M, Wang X, Pak M, et al. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2007 Nov 15;2(5):306-15 [Abstract]
Calvo-Calle JM, Strug I, Nastke MD, et al. Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog 2007 Oct 12;3(10):e144 [Full text]
Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005 Dec 7;294(21):2734-43 [Abstract]
CDC. 25th anniversary of the last case of naturally acquired smallpox. MMWR 2002 Oct 25; 51(42):952 [Full text]
CDC. Adverse events following civilian smallpox vaccination: United States, 2003. MMWR 2003 Aug 29;52(34):819-20 [Full text]
CDC. Advisory Committee on Immunization Practices (ACIP) statement on smallpox preparedneess and vaccination. Jun 18, 2003 [Full text]
CDC. Cardiac and other adverse events following civilian smallpox vaccination: United States, 2003. MMWR 2003 Jul 11;52(27):639-42 [Full text]
CDC. Cardiac deaths after a mass smallpox vaccination campaign: New York City, 1947. MMWR 2003 Oct 3;52(39):933-6 [Full text]
CDC. Cardiac-related events during the civilian smallpox vaccination program: United States, 2003. MMWR 2003 May 30;52(21):492-6 [Full text]
CDC. CDC interim guidance for revaccination of eligible persons who participated in the US civilian smallpox preparedness and response program. Released Jan 15, 2009 (but dated Oct 2008) [Full text]
CDC. Draft Guide A: Smallpox surveillance and case reporting; contact identification, tracing, vaccination, and surveillance; and epidemiologic investigation. Dec 30, 2003 [Full text]
CDC. Household transmission of vaccinia virus from contact with a military smallpox vaccinee--Illinois and Indiana, 2007. MMWR 2007 May 18;56(19):478-81 [Full text]
CDC. Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007. MMWR 2008 Apr 18;57(15):401-4 [Full text]
CDC. Laboratory-acquired vaccinia virus infection: Virginia, 2008. MMWR 2009 Jul 31;58(29):797-800 [Full text]
CDC. Negative staining electron microscopic protocol for rash illness. Revised Mar 2005 [Full text]
CDC. Preliminary report: multistate outbreak of monkeypox in persons exposed to pet prairie dogs. Jun 9, 2003 [Full text]
CDC. Progressive vaccinia in a military smallpox vaccinee--United States, 2009. MMWR 2009 May 19;58(Early release):1-4 [Full text]
CDC. Public health surveillance for smallpox--United States, 2003-2005. MMWR 2006 Dec 15;55(49):1325-7 [Full text]
CDC. Recommendations for using smallpox vaccine in a pre-event smallpox vaccination program. Supplemental recommendations of ACIP and HICPAC. MMWR 2003 Apr 4;52(RR07):1-16 [Full text]
CDC. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel: United States and worldwide, 2002-2004. MMWR 2004 Feb 13;53(5):103-5 [Full text]
CDC. Smallpox case definitions (as described in "Guide A" of the Smallpox Response Plan and Guidelines) [Full text]
CDC. Smallpox response plan and guidelines. Version 3.0. Updated Jun 25, 2004 [Full text]
CDC. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR 2003 Feb 21;52(RR04):1-28 [Full text]
CDC. Smallpox vaccination clinical guide. Released Sep 23, 2002 [Full text]
CDC. Smallpox vaccination information for women who are pregnant or breastfeeding. 2003 [Full text]
CDC. Smallpox vaccine adverse events monitoring and response system for the first stage of the smallpox vaccination program. MMWR 2002 Feb 7;52(5):88-9 [Full text]
CDC. Specimen collection of smallpox (vaccinia) vaccine virus [Full text]
CDC. Summary of October 2002 ACIP smallpox vaccination recommendations (updated Oct 21, 2002) [Full text]
CDC. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR 2003 Apr 4;52(13):282-4 [Full text]
CDC. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. From National Immunization Program. MMWR 2006 Feb 3;55(RR01):1-16 [Full text]
CDC. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 2001;50(10):1-25 [Full text]
CDC. Vaccinia virus infection after sexual contact with a military smallpox vaccinee--Washington, 2010. MMWR 2010 Jul 2;59(25):773-5 [Full text]
CDC. Vulvar vaccinia infection after sexual contact with a military smallpox vaccinee--Alaska, 2006. MMWR 2007 May 4;56(17):417-9 [Full text]
CDC. What you should know about a smallpox outbreak. Mar 29, 2004 [Web page]
CDC. Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry: United States, 2003. MMWR 2003 May 2;52(17):386-8 [Full text]
Chen Z, Earl P, Americo J, et al. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J Virol 2007 Sep;81(17):8989-95 [Abstract]
Chen Z, Earl P, Americo J, et al. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc Natl Acad Sci 2006 Feb 7;103(6):1882-7 [Abstract]
Chu CK, Jin YH, Baker RO, et al. Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (smallpox, monkeypox and cowpox). Bioorg Med Chem Lett 2003 Jan 6;13(1):9-12 [Abstract]
Cohen HW, Gould R, Sidel VW. Smallpox Vaccinations and adverse events. (Letter) JAMA 2006;295(16):1897-8 [Extract]
Cohen JI, Hohman P, Fulton R, et al. Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine. J Infect Dis 2010 Apr 15;201(8):1183-91 [Abstract]
Cohen JI, Hohman P, Preuss JC, et al. Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients. Vaccine 2007 Jun 6;25(23):4571-4 [Abstract]
Couch RB, Winokur P, Edwards KM, et al. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses. J Infect Dis 2007 Mar 15;195(6):826-32 [Abstract]
Cummings JF, Polhemus ME, Hawkes C, et al. Lack of vaccinia viremia after smallpox vaccination. Clin Infect Dis 2004 Feb 1;38(3):456-8 [Full text]
Cummings JF, Polhemus ME, Hawkes C, et al. Persistence of vaccinia at the site of smallpox vaccination. Clin Infect Dis 2008 Jan;46(1):101-2 [Full text]
Cunha BA. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room. Clin Microbiol Rev 2002 Aug 8(8):489-503 [Abstract]
Cunha BA. Smallpox and measles: historical aspects and clinical differentiation. Infect Dis Clin North Am 2004 Mar;18(1):79-100 [Abstract]
Damon IK, Davidson WB, Hughes CM, et al. Evaluation of smallpox vaccines using variola neutralization. J Gen Virol 2009 Aug;90(8):1962-6 [Abstract]
Davies DH, McCausland MM, Valdez C, et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 2005 Sep;79(18):11724-33 [Abstract]
Davies DW, Wyatt LS, Newman FK, et al. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus Ankara is comparable to that of Dryvax. J Virol 2008 Jan;82(2):652-63 [Abstract]
Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Vaccine 2008 Mar 17;26(12):1577-84 [Abstract]
Democratic members of the House Select Committee on Homeland Security. A biodefense failure: the National Smallpox Vaccination Program one year later. Jan 2004 [Full text]
Deng L, Dai P, Ciro A, et al. Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking viron assembly. J Virol 2007 Dec;81(24);13392-402 [Abstract]
Deria A. The emergency campaign for smallpox eradication from Somalia (1977-1979)--revisited. Vaccine 2011 (published online Dec 18) [Abstract]
Drazen JM. Smallpox and bioterrorism. (Perspective) N Engl J Med 2002;346(17):1262-3 [Full text]
Dropulic LK, Rubin RH, Bartlett JG. Smallpox vaccination and the patient with an organ transplant. Clin Infect Dis 2003 Mar 15;36(6):786-8 [Abstract]
Durrheim DN, Muller R, Saunders V, et al. Australian public and smallpox. Emerg Infect Dis 2005 Nov;11(11):1748-50 [Full text]
Dutta M, Basu RN. Lessons from smallpox eradication campaign in Bihar State and in India. Vaccine 2011 Mar 3;29(11):2005-7 [Abstract]
Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 2004(Mar 11);428(6979):182-5 [Abstract]
Earl PL, Americo JL, Wyatt LS, et al. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus. Proc Natl Acad Sci 2008 Aug 5;105(31):10889-94 [Full text]
Earl PL, Americo JL, Wyatt LS, et al. Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate. Virology 2007 Sep 15;366(1):84-97 [Abstract]
Eckart RE, Love SS, Atwood JE, et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 2004 Jul 7;44(1):201-5 [Abstract]
Eckart RE, Shry EA, Atwood JE, et al. Smallpox vaccination and ischemic coronary events in healthy adults. Vaccine 2007 Dec 5;25(50):8359-64 [Abstract]
Eichner M. Analysis of historical data suggests long-lasting protective effects of smallpox vaccination. Am J Epidemiol 2003 Oct 15;158(8):717-23 [Abstract]
Empig C, Kenner JR, Perret-Gentil M, et al. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine 2006 Apr 24;24(17):3686-94 [Abstract]
Engler RJ, Kenner J, Leung DY. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:357-65 [Abstract]
Esposito JJ, Sammons SA, Frace AM, et al. Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science 2006 Aug 11;313(5788):807-12 [Abstract]
Essbauer S, Meyer H, Porsch-Ozcurumez M, et al. Long-lasting stability of vaccinia virus (orthopoxvirus) in food and environmental samples. Zoonoses Public Health 2007 May;54(3-4):118-24 [Abstract]
Faden RR, Taylor HA, Seiler NK. Consent and compensation: a social compact for smallpox vaccine policy in the event of an attack. Clin Infect Dis 2003 Jun 15;36(12):1547-51 [Abstract]
Fauci AS, Challberg MD. Host-based antipoxvirus therapeutic strategies: turning the tables. (Commentary) J Clin Invest 2005 Feb 1:115(2):231-3 [Abstract - See also Yang below]
Fauci AS. Smallpox vaccination policy--the need for dialogue. (Editorial) N Engl J Med 2002;346(17):1319-20 [Full text]
FDA. Vaccinia virus: developing drugs to mitigate complications for smallpox vaccination. Draft guidance. Mar 2004 [Full text]
Federle CG, Negredo A, Molero F, et al. Use of internally controlled real-time genome amplification for detection of variola virus and other orthopoxviruses infecting humans. J Clin Microbiol 2006 Dec;44(12):4464-70 [Abstract]
Feldman KA, Enscore RE, Lathrop SL, et al. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol 2002 Apr;83(Pt 4):855-72 [Abstract]
Fenner F, Henderson DA, Arita I, et al. Smallpox and its eradication. Geneva, Switzerland: World Health Organization, 1988 [Full textbook]
Ferrier-Rembert A, Drillien R, Meignier B, et al. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate. Vaccine 2007 Nov 28;25(49):8290-7 [Abstract]
Ferrier-Rembert A, Drillien R, Tournier JN, et al. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine. Vaccine 2008 Mar 25;26(14):1794-804 [Abstract]
Foege W. Lessons and innovations from the West and Central African smallpox eradication program. Vaccine 2011 (published online Dec 19) [Abstract]
Foster SO, Hughes K, Tarantola D, et al. Smallpox eradication in Bangladesh, 1972-1976. Vaccine 2011 (published online Dec 19) [Abstract]
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51 [Abstract]
Frelinger JA, Garba ML. Responses to smallpox vaccine. (Letter) N Engl J Med 2002;347(9):689-90 [Full text]
Frey SE, Belshe RB. Poxvirus zoonoses: putting pocks into context. (Perspective) N Engl J Med 2004 Jan 22;359(4):324-7 [Extract]
Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002;346(17):1265-74 [Full text]
Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002;346(17):1275-80 [Full text]
Frey SE, Newman FK, Kennedy JS, et al. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000, and Dryvax in healthy vaccinia-naive adults. Vaccine 2009 Mar 4;27(10):1637-44 [Abstract]
Frey SE, Newman FK, Yan L, et al. Response to smallpox vaccine in persons immunized in the distant past. JAMA 2003 Jun 25;289(24):3295-9 [Abstract]
Fulginiti VA, Papier A, Lane JM, et al. Smallpox vaccination: a review, part I: background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis 2003 Jul 15;37(2):241-50 [Full text]
Fulginiti VA, Papier A, Lane JM, et al. Smallpox vaccination: a review, part II: adverse events. Clin Infect Dis 2003 Jul 15;37(2):251-71 [Full text]
Gallwitz S, Schutzbank T, Heberling RL, et al. Smallpox: residual antibody after vaccination. J Clin Microbiol 2003 Sep;41(9):3068-70 [Abstract]
Gammon DB, Snoeck R, Fiten P, et al. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral polymerase conferring differential resistance to antipoxvirus drugs. J Virol 2008 Dec;82(24):12520-34 [Abstract]
Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature 2001;414(Dec 13):748-51 [Abstract]
GAO (General Accounting Office). Smallpox vaccination: review of the implementation of the military program. Report to Senate Committee on Governmental Affairs. GAO-04-215R. Dec 1, 2003 [Full text]
Garcia AD, Meseda CA, Mayer AE, et al. Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines. Clin Vaccine Immunol 2007 Aug;14(8):1032-44 [Abstract]
Garde V, Harper D, Fairchok MP. Tertiary contact vaccinia in a breastfeeding infant. JAMA 2004 Feb 11;291(6):725-7 [Abstract]
Gassmann R, Engler O, Steffen R, et al. Clinical and immune response to undiluted and diluted smallpox vaccine. Swiss Med Wkly 2008 Jul 12;138(27-28):392-97 [Abstract - with link to full text]
Golovkin M, Spitsin S, Andrianov V, et al. Smallpox subunit vaccine produced in planta confers protection in mice. Proc Natl Acad Sci 2007 Apr 17;104(16):6864-9 [Abstract]
Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA 2003 Jun 25;289(24):3278-82 [Abstract]
Green S, Ennis FA, Mathew A. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines. Vaccine 2011 Feb 11;29(8):1666-76 [Abstract]
Greenberg RN, Kennedy JS, Clanton DJ, et al. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet 2005 Jan 29;365(9457):398-400 [Abstract - See also Poland below]
Greenberg RN, Schosser RH, Plummer EA, et al. Urticaria, exanthems, and other benign dermatologic reactions to smallpox vaccination in adults. Clin Infect Dis 2004 Apr 1;38(7):958-65 [Abstract]
Grosenbach DW, Jordan R, King DS, et al. Immune responses to the smallpox vaccine given in combination with ST-246, a small molecule inhibitor of poxvirus dissemination. Vaccine 2008 Feb 13;26(7):933-46 [Abstract]
Gubser C, Smith GL. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol 2002;83(4):855-72 [Full text]
Haim M, Gdalevich M, Mimouni D, et al. Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys. Mil Med 2000;165(4):287-9 [Abstract]
Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003 Jun 25;289(24):3283-9 [Abstract]
Hammarlund E, Lewis MW, Carter SV, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med 2005 Sep;11(9):1005-11 [Full text]
Hammarlund E, Lewis MW, Hanifin JM, et al. Antiviral immunity following smallpox infection: a case-control study. J Virol 2010 Dec;84(24):12754-60 [Abstract]
Hammarlund E, Lewis MW, Hanifin JM, et al. Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment. Vaccine 2008 Jan 17;26(3):430-9 [Abstract]
Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nature Med 2003 Sep 1;9(9):1131-7 [Abstract]
Hammond E. Should the US and Russia destroy their stocks of smallpox virus? (head-to-head) BMJ 2007 Apr 14;334(7597):774 [Excerpt]
Handley L, Buller MB, Frey SE, et al. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks. Expert Rev Vaccines 2009 Jul;8(7):841-50 [Abstract]
Hanrahan JA, Jakubowycz M, Davis BR. A smallpox false alarm. (Letter) N Engl J Med 2003;348(5):467-8 [Citation]
Harrison SC, Alberts B, Ehrenfeld E, et al. Discovery of antivirals against smallpox. (Perspective) Proc Natl Acad Sci 2004 Aug 3;101(31):11178-92 [Extract]
Hatakeyama S, Moriya K, Saijo M, et al. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations. Clin Diag Lab Immunol 2005 Apr;12(4):520-4 [Abstract]
He Y, Manischewitz J, Meseda CA, et al. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine-induced immunity. J Infect Dis 2007 Oct 1;196(7):1026-32 [Abstract]
Henderson DA, Fenner F. Recent events and observations pertaining to smallpox virus destruction in 2002. Clin Infect Dis 2001;33:1057-8 [Abstract]
Henderson DA, Inglesby TV, Bartlett JG, et al, for the Working Group on Civilian Biodefense. Smallpox as a biological weapon: medical and public health management. JAMA 1999;281(22):2127-37 [Abstract]
Henderson DA. Smallpox virus destruction and the implications of a new vaccine. (Commentary) Biosecurr Bioterror 2011 May 25;9(2):163-8 [Abstract]
Henderson DA. Smallpox: clinical and epidemiologic features. Emerg Infect Dis 1999;5(4):537-9 [Full text]
Henderson DA. The eradication of smallpox--an overview of the past, present, and future. Vaccine 2011 (published online Dec 19) [Abstract]
HHS. Declaration regarding administration of smallpox countermeasures. Fed Reg 2003 Jan 28;68(18):4212-3 (Effective as of Jan 24, 2003) [Full text]
HHS. HHS issues final rule for smallpox vaccine injury compensation program. Jun 16, 2006 [Press release]
HHS. Smallpox vaccine injury compensation program: administrative implementation; interim final rule. 42 CFR Pt 102. Fed Reg 2003 Dec 16;68(231):70079-106 [Abstract]
HHS. Smallpox vaccine injury compensation program: smallpox (vaccinia) vaccine injury table. 42 CFR Pt 102. Fed Reg 2003 Aug 27;68(166):51492-9 [Full text]
Hirao LA, Draghia-Akli R, Prigge JT, et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation dries protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis 2011 Jan;203(1):95-102 [Abstract]
Hixson KK, Adkins JN, Baker SE, et al. Biomarker candidate identification in Yersinia pestis using organism-wide semiquantitative proteomics. J Proteome Res 2006 Nov;5(11):3008-17 [Abstract]
Hooper JW, Golden JW, Ferro AM, et al. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007 Feb 26;25(10):1814-23 [Abstract]
Hooper JW, Thompson E, Wilhelmsen C, et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 2004 May;78(9):4433-43 [Abstract]
Hopkins RJ, Kramer WG, Blackwelder WC, et al. Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Clin Infect Dis 2004 Sep 15;39(6):759-66 [Abstract]
Howell MD, Gallo RL, Boguniewicz M, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006 Mar;24:341-8 [Abstract]
Howell MD, Jones JF, Kisich KO, et al. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 2004 Feb 1;172(3):1763-7 [Abstract]
Hsieh S-M, Pan S-C, Chen S-Y, et al. Age distribution for T cell reactivity to vaccinia virus in a healthy population. Clin Infect Dis 2004 Jan 1;38(1):86-9 [Abstract]
Hsieh SM, Chen SY, Sheu GC, et al. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain. Vaccine 2006 Jan 23;24(4):510-5 [Abstract]
Huang X, Lu B, Yu W, et al. A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. PLoS ONE 2009 Jan 9;4(1):e4180 [Full text]
Huerta M, Balicer RD, Mimouni D, et al. Validity of self-assessment of skin reaction after smallpox vaccination. Public Health Rep 2006 Jan-Feb;121(1):45-50 [Abstract]
Huggins J, Goff A, Hensley L, et al. Non-human primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 2009 Jun;53(6):2620-5 [Abstract]
Hughes CM, Blythe D, Li Y, et al. Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerg Infect Dis 2011 Apr;17(4):730-3 [Full text]
Hutchens MA, Luker KE, Sonstein J, et al. Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog 2008 Sep 19;4(9):e1000153 [Full text]
IOM (Institute of Medicine). Live variola virus: considerations for continuing research. IOM report released July 10, 2009 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 1. Washington, DC: National Academies Press. Jan 16, 2003 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 2. Washington, DC: National Academies Press. Mar 21, 2003 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 3. Washington, DC: National Academies Press. May 23, 2003 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 4. Washington, DC: National Academies Press. Aug 12, 2003 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 5. Washington, DC: National Academies Press. Dec 19, 2003 [Full text]
IOM (Institute of Medicine). Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation: letter report 6. Washington, DC: National Academies Press. Jul 6, 2004 [Full text]
IOM. The smallpox vaccination program: public health in an age of terrorism. Unedited copy. Mar 2005 [Full text]
Jackson RL, Ramsay AJ, Christensen CD, et al. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virology 2001;75(3):1205-10 [Abstract]
Jacobs N, Chen RAJ, Gubser C, et al. Intradermal immune response after infection with vaccinia virus. J Gen Virol 2006 May;87(Pt 5):1157-61 [Abstract]
Jacobson IG, Smith TC, Smith B, et al. US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination. Vaccine 2008 Jul 29;26(32):4048-56 [Abstract]
Jahrling PB, Hensley LE, Martinez MJ, et al. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci 2004 Oct 19;101(42):15196-200 [Abstract]
Jentarra GM, Heck MC, Youn JW, et al. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine 2008 Jun 2;26(23):2860-72 [Abstract]
Johnson BF, Kanatani Y, Fujii T, et al. Serological responses in humans to smallpox vaccine LC16m8. J Gen Virol 2011 Oct;92(Pt 10):2405-10 [Abstract]
Jones T. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection. Curr Opin Mol Ther 2008 Aug;10(4):407-17 [Abstract]
Jordan R, Goff A, Frimm A, et al. ST-246 antiviral efficacy in a non-human primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother 2009 May;53(5):1817-22 [Abstract]
Jordan R, Tien D, Bolken TC, et al. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor. Antimicrob Agents Chemother 2008 May;52(5):1721-7 [Abstract]
Kastenmuller W, Gasteiger G, Stross L, et al. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens. J Immunol 2009 Mar 1;182(5):2573-7 [Abstract]
Keasey S, Pugh C, Tikhonov A, et al. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLoS ONE 2010 Dec 30;5(12):e15547 [Full text]
Keckler MS, Carroll DS, Gallardo-Romero NF, et al. Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered pre-exposure in both high and low-dose monkeypox challenges. J Virol 2011 (published online Jun 1) [Abstract]
Kemper AR, Cowan AE, Ching PL, et al. Hospital decision-making regarding the smallpox pre-event vaccination program. Biosec Bioterror 2005;3(1):23-30 [Abstract]
Kemper AR, Davis MM, Freed GL. Expected adverse events in a mass smallpox vaccination campaign. Effect Clin Pract 2002;5(2):84-6 [Full text]
Kennedy JS, Frey SE, Yan L, et al. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. J Infect Dis 2004 Oct 1;190(7):1286-94 [Abstract]
Kennedy JS, Gurwith M, Dekker CL, et al. Safety and immunogenicity of LC16ms8, an attenuated smallpox vaccine in vaccinia-naive adults. J infect Dis 2011 (published online Sep 15) [Abstract]
Kerrod E, Geddes AM, Regan M, et al. Surveillance and control measures during smallpox outbreaks. Emerg Infect Dis 2005 Feb;11(2):291-7 [Full text]
Kiang KM, Krathwohl MD. Rates and risks of transmission of smallpox and mechanisms of prevention. J Lab Clin Med 2003 Oct;142(4):229-38 [Abstract]
Kim SH, Bang JW, Park KH, et al. Prediction of residual immunity to smallpox, by means of an interdermal skin test with inactivated vaccinia virus. J Infect Dis 2006 Aug 1;194(3):377-84 [Abstract]
Kim SH, Choi SJ, Park WB, et al. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine 2007 Aug 14;25(33):6287-91 [Abstract]
Kim SH, Yeo SG, Cho JH, et al. Cell-mediated immune responses to smallpox vaccination. Clin Vaccine Immunol 2006 Oct;13(10):1172-4 [Abstract]
Kim SH, Yeo SG, Jang HC, et al. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 2005 Sep 15;192(6):1066-72 [Abstract]
Kim Y-G, Lowenhaupt K, Oh D-B, et al. Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: implications for development of a therapy for poxvirus infection. Proc Natl Acad Sci 2004 Feb;101(6):1514-8 [Abstract]
Kornbluth RS, Smee DF, Sidwell RW, et al. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrob Agents Chemother Dec 2006;50(12):4038-43 [Abstract]
Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (eg, HIV), potentially pandemic (eg, H5N1 strain of influenza) and carcinogenic (eg, HBV and HCV) viruses, and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine 2008 Jun 6;26(24):3055-8 [Abstract]
Kretzschmar M, van den Hof S, Wallinga J, et al. Ring vaccination and smallpox control. Emerg Infect Dis 2004 May;10(5):832-41 [Full text]
Kretzschmar M, Wallinga J, Teunis P, et al. Frequency of adverse events after vaccination with different vaccinia strains. PLoS Med 2006 Aug;3(8):e272 [Full text]
Kuhles DJ, Ackman DV. The federal smallpox vaccination program: where do we go from here? Health Affairs 2003 Oct 22;W3:503-10 [Full text]
Kurth A, Achenbach J, Miller L, et al. Orthopoxvirus detection in environmental specimens during suspected bioterror attacks: inhibitory influences of common household products. Appl Environ Microbiol 2008 Jan;74(1):32-7 [Abstract]
Lane JM, Goldstein J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann Intern Med 2003 Mar 18;138(6):488-93 [Full text]
Lane JM, Poland GA. Why not destroy the remaining smallpox virus stocks? (Editorial) Vaccine 2011 Apr 5;29(16):2823-4 [Full text]
Lantto J, Hansen MH, Rasmussen SK, et al. Capturing the natural diversity of the human antibody response against vaccinia virus. J Virol 2011 Feb;85(4):1820-33 [Abstract]
Lawrence SJ, Lottenbach KR, Newman FK, et al. Antibody responses to vaccinia membrane proteins after smallpox vaccination. J Infect Dis 2007 Jul 15;196(2):220-9 [Abstract]
Lederman E, Miramontes R, Openshaw J, et al. Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment. Vaccine 2009 Jan 14;27(3):375-7 [Abstract]
LeDuc JW, Damon I, Meegan JM, et al. Smallpox research activities: US Interagency collaboration, 2001. Emerg Infect Dis 2002 Jul;8(7):743-5 [Full text]
Legrand J, Viboud C, Boelle PY, et al. Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiol Infect 2004 Jan;132(1):19-25 [Abstract]
Lewis FM, Chernak E, Goldman E, et al. Ocular vaccinia infection in laboratory worker, Philadelphia, 2004. Emerg Infect Dis 2006 Jan;12(1):134-7 [Full text]
Li H, Deetz CO, Zapata JC, et al. Vaccinia virus inhibits T cell receptor-dependent responses by human [gamma-delta] T cells. J Infect Dis 2007 Jan;195(1):37-45 [Abstract]
Lindley MC, Wortley PM, Winston CA, et al. Programmatic factors related to smallpox vaccine uptake by healthcare workers and others. Infect Control Hosp Epidemiol 2006 Nov;27(11):1242-5 [Abstract]
Liu L, Zy X, Fuhlbrigge RC, et al. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J Virol 2005 Jun;79(12):7363-70 [Abstract]
Mack T. Stockpiling smallpox virus. (editorial) BMJ 2007 Apr 14;334(7597):760 [Excerpt]
Madeley CR. Diagnosing smallpox in possible bioterrorist attack. (Editorial) Lancet 2003 Jan 11;361(9352):97-8 [Full text]
Malone JD. Pre-event smallpox vaccination for healthcare workers revisited--the need for a carefully screened multidisciplinary cadre. Int J Infect Dis 2007 Mar;11(2):93-7 [Abstract]
Manischewitz J, King LR, Bleckwenn NA, et al. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis 2003 Aug 1;188(3):440-8 [Abstract]
Marriott KA, Parkinson CV, Morefield SI, et al. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine 2008 Jan 24;26(4):581-8 [Abstract]
Marshall KM, Begier EM, Griffith KS, et al. A population survey of smallpox knowledge, perceptions, and healthcare-seeking behavior surrounding the Iraq invasion--Connecticut 2002-03. Biosecur Bioterror 2005;3(3):246-55 [Abstract]
Massoudi MS, Barker L, Schwartz B. Effectiveness of postexposure vaccination for the prevention of smallpox: results of a Delphi analysis. J Infect Dis 2003 Oct 1;188(7):973-6 [Abstract]
McClain DJ. Smallpox. In: Zajtchuk R, Bellamy RF, eds. Textbook of military medicine: medical aspects of chemical and biological warfare. Chap 27. Washington, DC: Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center. [Full text]
McCurdy LH, Larkin BD, Martin JE, et al. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin Infect Dis 2004 Jun 15;38(12):1749-53 [Abstract]
McCurdy LH, Rutigliano JA, Johnson TR, et al. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. J Virol 2004 Nov;78(22):12471-9 [Abstract]
McDevitt JJ, Lai KM, Rudnick SN, et al. Characterization of UVC light sensitivity of vaccinia virus. Appl Environ Microbiol 2007 Sep;73(18);5760-6 [Abstract]
McDevitt JJ, Milton DK, Rudnick SN, et al. Inactivation of poxviruses by upper-room UVC light in a simulated hospital room environment. PLoS ONE 2008 Sep 10;3(9):e3186 [Full text]
McFadden G. Killing a killer: what next for smallpox? (Commentary) PLoS Pathog 2010 Jan 29;6(1):e1000727 [Full text]
McKenzie FE. Smallpox models as policy tools. (Conference Report) Emerg Infect Dis 2004 Nov;10(11):2044-7 [Full text]
McKinney BA, Reif DM, Rock MT, et al. Cytokine expression patterns associated with systemic adverse events following smallpox immunization. J Infect Dis 2006 Aug 15;194(4):444-53 [Abstract]
McSharry JJ, Deziel MR, Zager K, et al. Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow fiber infection model (HFIM) system. Antimicrob Agents Chemother 2009 Jan;53(1):129-35 [Abstract]
Melekhin VV, Karem KL, Damon IK, et al. Encephalitis after secondary smallpox vaccination. Clin Infect Dis 2009 Jan 1;48(1):e1-e2 [Abstract]
Meltzer MI, Damon I, LeDuc J, et al. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis 2001 Nov-Dec;7(6):959-69 [Full text]
Meltzer MI. Risks and benefits of preexposure and postexposure smallpox vaccination. (Perspective) Emerg Infect Dis 2003 Nov;9(11):1363-70 [Full text]
Merkel TJ, Perera PY, Kelly VK, et al. Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities. Proc Natl Acad Sci 2010 Oct 19;107(42):18091-6 [Abstract]
Midgley CM, Putz MM, Weber JN, et al. Vaccinia virus strain NYVAC induces substantially lower and quantitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol 2008 Dec;89(12):2992-7 [Full text]
Miller JD, van der Most RG, Akondy RS, et al. Human effector and memory CD+8 T-cell responses to smallpox and yellow fever vaccines. Immunity 2008 May 16;28(5):710-22 [Abstract]
Miller JR, Cirino NM, Philbin EF. Generalized vaccinia 2 days after smallpox vaccination. (Letter) Emerg Infect Dis 2003 Dec;9(12):1649-50 [Full text]
Miller SE. Bioterrorism and electron microscopic differentiation of poxviruses from herpesviruses: dos and don'ts. Ultrastruct Pathol 2003 May-Jun;27(3):133-40 [Abstract]
Mohamed A, Sharron SS, Park K, et al. Dual-probe real-time PCR assay for detection of variola or other orthopoxviruses with dried reagents. J Virol Methods 2008 Nov;153(2):190-5 [Abstract]
Moore ZS, Seward JF, Lane JM. Smallpox. Lancet 2006 Feb 4;367(9508):425-35 Review [Abstract]
Moore ZS, Seward JF, Watson BM, et al. Chickenpox or smallpox: the use of the febrile prodrome as a distinguishing characteristic. Clin Infect Dis 2004;39(12):1810-7 [Abstract]
Mortimer PP. Can postexposure vaccination against smallpox succeed? Clin Infect Dis 2003 Mar 1;36(5):622-9 [Abstract]
Mortimer PP. The new cell culture smallpox vaccine should not be offered to the general population. Rev Med Virol 2003 Jan-Feb;13(1):17-20 (see also Bicknell 2003 above) [Full text]
Mota BEF, Gallardo-Romero N, Trindade G, et al. Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus. PLoS ONE 2011 Apr 15;6(4):e18924 [Full text]
Moussatche N, Tuyama M, Kato SEM, et al. Accidental infection of laboratory worker with vaccinia virus. Emerg Infect Dis 2003 Jun 9(6):724-6 [Full text]
Murphy FA, Osburn BI. Adventitious agents and smallpox vaccine in strategic national stockpile. Emerg Infect Dis 2005 Jul;11(7):1086-9 [Full text]
Muyembe-Tamfum JJ, Mulembakani P, Lekie RB, et al. Smallpox and its eradication in the Democratic Republic of Congo: lessons learned. Vaccine 2011 (published online Dec 19) [Abstract]
Naleway AL, Belongia EA, Greenlee RT, et al. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med 2003 Jul 1;139(1):1-7 [Full text]
Neff JM, Lane JM, Eulginiti VA, et al. Contact vaccinia: transmission of vaccinia from smallpox vaccination. (Commentary) JAMA 2002;288(15):1901-5 [Full text]
Nishiura H, Brockmann SO, Eichner M. Extracting key information from historical data to quantify the transmission dynamics of smallpox. Theor Biol Med Model 2008 Aug 20;5(1):20 [Abstract]
Nishiura J. Smallpox during pregnancy and maternal outcomes. Emerg Infect Dis 2006 Jul;12(7):1119-21 [Full text]
Niska RW, Burt CW. Training for terrorism-related conditions in hospitals: United States, 2003-04. Adv Data 2006 Dec 11;(380):1-9 [Full text]
Nuovo GJ, Plaza JA, Magro C. Rapid diagnosis of smallpox infection and differentiation from its mimics. Diag Mol Pathol 2003 Jun;12(2):103 [Abstract]
O'Brien KK, Higdon NL, Halverson JJ. Recognition and management of bioterrorism infections. Am Fam Physician 2003 May 1;67(9):1927-34 [Full text]
O'Toole T, Mair M, Inglesby TV. Shining light on 'Dark Winter.' Clin Infect Dis 2002;34(7):972-83 [Full text]
Olmsted SS, Grabenstein JD, Jain AK, et al. Use of an electronic monitoring system for self-reporting smallpox vaccine reactions. Biosec Bioterr 2005 Sep;3(3):198-206 [Abstract]
Olson VA, Karem KL, Smith SK, et al. Smallpox virus plaque phenotypes: genetic, geographical, and case fatality relationships. J Gen Virol 2009 Apr;90(4):792-8 [Abstract]
Olson VA, Laue T, Laker MT, et al. Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol 2004 May;42(5):1940-6 [Abstract]
Orr N, Forman M, Marcus H, et al. Clinical and immune responses after revaccination of Israeli adults with the Lister strain of vaccinia virus. J Infect Dis 2004 Oct;190(7):1295-302 [Abstract]
Ostrout ND, McHugh MM, Tisch DJ, et al. Long-term T cell memory to human leucoctye antigen-A2 supertype epitopes in humans vaccinated against smallpox. Clin Exp Immunol 2007 Aug;149(2):265-73 [Abstract]
Paran N, Suezer Y, Lustig S, et al. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. J Infect Dis 2009 Jan 1;199(1):39-48 [Abstract]
Parrino J, McCurdy LH, Larkin BD, et al. Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax (R) challenge in vaccinia-naive and vaccinia-immune individuals. Vaccine 2007 Feb 9;25(8):1513-25 [Abstract]
Perera LP, Waldmann TA, Mosca JD, et al. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice. J Virol 2007 Aug;81(16):8774-83 [Abstract]
Poland G. Smallpox vaccines: from first to second to third generation. (Comment on Greenberg article above) Lancet 2005 Jan 29;365(9457):362-3 [Full text - Access requires free registration]
Poland GA, Neff JM. Smallpox vaccine: problems and prospects. Immunol Allergy Clin North Am 2003 Nov;23(4):731-43 [Abstract]
Portocarrero C, Markley K, Koprowski H, et al. Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5. Vaccine 2008 Oct 9;26(43):5535-40 [Abstract]
Pritchard MN, Keith KA, Johnson MP, et al. Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase. Antimicrob Agents Chemother 2007 May;51(5):1795-803 [Abstract]
Putkuri N, Piiparinen H, Vaheri A, et al. Detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time PCR. J Med Virol 2009 Jan;81(1):146-52 [Abstract]
Putz MM, Midgley CM, Law M, et al. Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination. Nature Med 2006 Nov;12(11):1310-5 [Abstract]
Quenelle DC, Buller RM, Parker S, et al. Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice. Antimicrob Agents Chemother 2007 Feb;51(2):689-95 [Abstract]
Quenelle DC, Prichard MN, Keith KA, et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimcrob Agents Chemother 2007 Nov;51(11):4118-24 [Abstract]
Quixabeira-Santos JC, Medaglia MLG, Pescador CA, et al. Animal movement and establishment of vaccinia virus Cantagalo strain in Amazon biome, Brazil. Emerg Infect Dis 2011 Apr;17(4):726-9 [Full text]
Reeves PM, Bommarius B, Lebeis S, et al. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nature Med 2005 Jul;11(7):731-9 [Abstract]
Regules JA, Dooley DP, Hepburn MJ, et al. The effect of semipermeable dressings on smallpox vaccine site evolution. Am J Infect Control 2004 Oct;32(6):333-6 [Abstract]
Reif DM, McKinney BA, Motsinger AA, et al. Genetic basis for adverse events after smallpox vaccination. J Infect Dis 2008 Jul 1;198(1):16-22 [Full text - see Relman commenary below]
Relman DA. Learning to appreciate our differences. (Commentary) J Infect Dis 2008 Jul 1;198(1):4-5 [Full text - see Reif article above]
Riley S. Large-scale spatial-transmission models of infectious disease. Science 2007 Jun 1;316(5829):1298-301 [Abstract]
Rock MT, Yoder SM, Talbot TR, et al. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. JID 2004 Apr 15;189(8):1401 [Abstract]
Rosengard AM, Liu Y, Zhiping N, et al. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Nat Acad Sci 2002;99(13):8808-13 [Full text]
Roy CJ, Baker R, Washburn K, et al. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrob Agents Chemother 2003 Sep;47(9):2933-7 [Abstract]
Rubins KH, Hensley LE, Jahrling PB, et al. The host response to smallpox: Analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci 2003 Oct 19;101(42):15190-5 [Abstract]
Ryan MA, Gumbs GR, Conlin AM, et al. Evaluation of preterm births and birth defects in liveborn infants of US military women who received smallpox vaccine. Birth Defects Res A Clin Mol Teratol 2008 Jul;82(7):533-9 [Abstract]
Saito T, Fujii T, Kanatani Y, et al. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. JAMA 2009 Mar 11;301(10):1025-33 [Full text]
Sakhatskyy P, Wang S, Zhang C, et al. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens. Virology 2008 Feb 5;371(1):98-107 [Abstract]
Savona MR, Dela Cruz WP, Jones JS, et al. Detection of vaccinia DNA in the blood following smallpox vaccination. (Research Letter) JAMA 2006 Apr 26;295(16):1898-900 [Extract]
Scaramozzino N, Ferrier-Rembert A, Favier AL, et al. Real-time PCR to identify variola virus or other human pathogenic orthopox viruses. Clin Chem 2007 Apr;53(4):606-13 [Abstract]
Sejvar JJ, Labutta RJ, Chapman LE, et al. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 2003 Dec 7;294(21):2744-50 [Abstract]
Semba RD. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol 2003 May;121(5):715-9 [Abstract]
Sepkowitz KA. How contagious is vaccinia? N Engl J Med 2003 Jan 30;348(5):439-46 [Full text]
Seward JF, Galil K, Damon I, et al. Development and experience with an algorithm to evaluate suspected smallpox cases in the United States, 2002-2004. Clin Infect Dis 2004 Nov 15;39(10):1477-83 [Abstract]
Seward JF, Zhang JX, Maupin TJ, et al. Contagiousness of varicella in vaccinated cases. JAMA 2004 Aug 11;292(6):704-8 [Abstract]
Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol 2003 Jul;41(7):2801-9 [Abstract]
Shaklee JF, Talbot TR, Muldowney JA, et al. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins associated with ischemic cardiac events. J Infect Dis 2005 Mar 1;191(5):724-30 [Abstract]
Sharon M, Nir P, Lior K, et al. Tail scarification with vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice. Vaccine 2007 Nov 7;25(45):7743-53 [Abstract]
Shchelkunov SN. Emergence and reemergence of smallpox: the need in development of a new generation smallpox vaccine. Vaccine 2011 (published online Dec 18) [Abstract]
Shisler JL, Jin X-L. The vaccinia virus K1L product inhibits host NF-kB activation by preventing IkBa degradation. J Virol 2004 Apr;78(7):3553-60 [Abstract]
Silva-Fernandes AT, Travassos CE, Ferreira JM, et al. Natural human infections with vaccinia virus during bovine vaccinia outbreaks. J Clin Virol 2009 Apr;44(4):308-13 [Abstract]
Simpson EL, Hercher M, Hammarlund EK, et al. Cutaneous responses to vaccinia in individuals with previous smallpox vaccination. J Am Acad Dermatol 2007 Sep;57(3):442-4 [Abstract]
Sivapalasingam S, Kennedy JS, Borkowsky W, et al. Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. J Infect Dis 2007 Apr 15;195(8):1151-9 [Abstract]
Smee DF, Bailey KW, Wong MH, et al. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. J Infect Dis 2004 Sep 15;190(6):1132-9 [Abstract]
Smith PF, Chang H-G, Sepkowitz KA. Inpatients at risk of contact vaccinia from immunized health care workers. JAMA 2003 Mar 26;289(12):1512-3 [Full text]
Smith SK, Olson VA, Karem KL, et al. In vitro efficacy of ST246 against smallpox and monkeypox. Antimicrob Agents Chemother 2009 Mar;53(3):1007-12 [Abstract]
Smith SK, Olson VA, Karem KL, et al. ST246 in vitro efficacy against smallpox and monkeypox. Antimicrob Agents Chemother 2008 (published online Dec 15) [Abstract]
Sorup S, Villumsen M, Ravn H, et al. Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. Int J Epidemiol 2011 Aug;40(4):955-63 [Abstract]
Stanley SL Jr, Frey SE, Taillon-Miller P, et al. The immunogenetics of smallpox vaccination. J Infect Dis 2007 Jul 15;196(2):212-9 [Abstract]
Stittelaar KJ, Neyts J, Naesens L, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. (Letter) Nature 2006 Feb 9;439(7077):745-8 [Abstract]
Suarez VR, Hankins GD. Smallpox and pregnancy: from eradicated disease to bioterrorist threat. Obstet Gynecol 2002 Jul;100(1):87-93 [Abstract]
Sulaiman IM, Tang K, Osborne J, et al. GeneChip resequencing of the smallpox virus genome can identify novel strains: a biodefense application. J Clin Microbiol 2007 Feb;45(2):358-63 [Abstract]
Talbot TR, Bredenberg K, Smith M, et al. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA 2003 Jun 25;289(24):3290-4 [Abstract]
Talbot TR, Peters J, Wright PF, et al. Absence of pharyngeal shedding of vaccinia following smallpox vaccination. Am J Infect Control 2007 Sep;25(7):486-8 [Abstract]
Talbot TR, Stapleton JT, Brady RC, et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 2004 Sep 8;292(10):1205-12 [Abstract]
Talbot TR, Ziel E, Doersam JK, et al. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Clin Infect Dis 2004 Feb 15;38(4):536-41 [Abstract]
Tarantola D, Foster SO. From smallpox eradication to contemporary global health initiatives: enhancing human capacity towards a global public health goal. Vaccine 2011 (published online Dec 18) [Abstract]
Tasker SA, Schnepf GA, Lim M, et al. Unintended smallpox vaccination of HIV-1-infected individuals in the United States military. Clin Infect Dis 2004 May 1;38(9):1320-2 [Abstract]
Taub DD, Ershler WB, Janowski M, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. Am J Med 2008 Dec;121(12):1058-64 [Abstract]
Thorpe LE, Mostashari F, Karpati AM, et al. Mass smallpox vaccination and cardiac deaths, New York City, 1947. Emerg Infect Dis 2004 May;10(5):917-20 [Full text]
Trindade GS, Emerson GL, Carroll DS, et al. Brazilian vaccinia viruses and their origins. Emerg Infect Dis 2007 Jul;13(7):965-72 [Full text]
Tse-Dinh YC. An update on the development of drugs against smallpox. Curr Opin Investig Drugs 2008 Aug;9(8):865-70 [Abstract]
Tucker JB, Zilinskas RA. CNS Occasional Paper No 9: The 1971 smallpox epidemic in Aralsk, Kazakhstan, and the Soviet biological warfare program. June 2002 [Full text]
Tucker JB. Breaking the deadlock over destruction of the smallpox virus stocks. (Commentary) Biosecur Bioterror 2011 Mar;9(1):55-67 [Extract]
Vellozzi C, Averhoff F, Lane JM, et al. Superinfection following smallpox vaccination (vaccinia), United States: surveillance January 2003 through January 2004. Clin Infect Dis 2004 Dec 1;39(11):1660-6 [Abstract]
Vellozzi C, Land MJ, Averhoff F, et al. Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003. Clin Infect Dis 2005 Sep 1;41(5):689-97 [Abstract]
Vijaysri S, Jentarra G, Heck MC, et al. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intral-nasal vaccination. Vaccine 2008 Jan 30;26(5):664-76 [Abstract]
Vollmar J, Arndtz N, Eckl KM, et al. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine 2006 Mar 15;24(12):2065-70 [Abstract]
Waibel KH, Ager EP, Topolski RL, et al. Randomized trial comparing vaccinia on the external surfaces of 3 conventional bendages applied to smallpox vaccination sites in primary vaccinees. Clin Infect Dis 2004 Oct 1;39(7):1004-7 [Abstract]
Waibel KH, Golding H, Manischewitz J, et al. Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults. Clin Infect Dis 2006 Feb 15;42(4):e16-20 [Abstract]
Wei H, Huang D, Fortman J, et al. Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited responses and immunity to monkeypox. J Virol 2009 Jan;83(2):1115-25 [Abstract]
Weinstein RS. Should remaining stockpiles of smallpox virus (variola) be destroyed? Emerg Infect Dis 2011 Apr;17(4):681-3 [Full text]
Weiss MM, Weiss PD, Mathisen G, et al. Rethinking smallpox. Clin Infect Dis 2004 Dec 1;39(11):1668-73 [Abstract]
Weltzin R, Liu J, Pugachev KV, et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nature Med 2003 Sep;9(9):1125-30 [Abstract]
Wertheimer ER, Olive DS, Brundage JF, et al. Contact transmission of vaccinia virus from smallpox vaccinees in the United States, 2003-2011. Vaccine 2011 (published online Dec 20) [Abstract]
Wickett J, Carrasco P. Logistics in smallpox: the legacy. Vaccine 2011 (published online Dec 19) [Abstract]
Wilck MB, Seaman MS, Baden LR, et al. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis 2010 May 1;201(9):1361-70 [Abstract]
Wiser I, Balicer RD, Cohen D. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Vaccine 2007 Jan 22;25(6):976-84 [Abstract]
Wiser I, Orr N, Smetana Z, et al. Alternative immunological markets to document successful multiple smallpox revaccinations. Clin Infect Dis 2011 Apr 1;52(7):856-61 [Abstract]
Wortley PM, Schwartz B, Levy PS, et al. Healthcare workers who elected not to receive smallpox vaccination. Am J Prev Med 2006 Mar;30(3):258-65 [Abstract]
Wright ME, Fauci AS. Smallpox immunization in the 21st century: the old and the new. (Editorial) JAMA 2003;289(24):3306-8 [Full text]
Wyatt LS, Earl PL, Eller LA, et al. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci 2004 Mar 30;101(13):4590-5 [Abstract]
Xiao Y, Aldaz-Carroll L, Ortiz AM, et al. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost. Vaccine 2007 Jan 26;25(7):1214-24 [Abstract]
Yang H, Kim SK, Kim M, et al. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest 2005 Feb 1;115(2):379-87 [Abstract - See also Fauci and Challberg above]
Yang P, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 2005 Oct;79(20):13139-49 [Abstract]
Young GE, Hidalgo CM, Sullivan-Frohm A, et al. Secondary and tertiary transmission of vaccinia virus from US military service member. Emerg Infect Dis 2011 Apr;17(4):718-21 [Full text]
Zielinski RJ, Smedley JV, Perera PY, et al. Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys. Vaccine 2010 Oct 8;28(43):7081-91 [Abstract]
|
